“Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis-Reference-Cited by-同舟云学术

“Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis

Published:2015-05 Issue:20 Volume:290 Page:12650-12663
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ho Chia Chi M.,Guo Nan,Sockolosky Jonathan T.,Ring Aaron M.,Weiskopf Kipp,Özkan Engin,Mori Yasuo,Weissman Irving L.,Garcia K. Christopher

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference61 articles.

1. Macrophage biology in development, homeostasis and disease;Wynn;Nature,2013

2. Distinct role of macrophages in different tumor microenvironments;Lewis;Cancer Res,2006

3. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans;Beatty;Science,2011

4. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia;Chao;Cancer Res,2011

5. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma;Chao;Cell,2010

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In situ reprogramming of tumor-associated macrophages enhances cancer immunotherapy;Nano Today;2024-10

2. Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy;ACS Nano;2024-08-08

3. Erythrocyte Membrane Coating Alleviate Immune Response and Promoted Adipogenesis in Adipose Matrix;Tissue Engineering Part A;2024-06-27

4. Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation;Materials Today Bio;2024-06

5. A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma;Current Oncology;2024-06-01